0

Podcast Q&A: Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations

This podcast segment from Self Care Catalysts’ June 29, 2022 webinar features the Q&A with Renee Willmon, MSc, Senior Director, Evidence and Outcomes, Global Market Access.     There is often a conflict between the protocol requirements to efficiently demonstrate… Continue Reading

0

Using Innovative Data Analytics for Market Access

Dr. Patti Peeples, CEO of HealthEconomics.com, sat down with Walter Bouwmeester, Real-World Evidence and Data Analytics Lead in Europe, to discuss the use of data analytics to support multidimensional health economics and outcomes research (HEOR) in Europe. Continue Reading

0

Diabetes Trends in the U.S.

PATIENT AWARENESS AND IMPACT ON OUTCOMES Diabetes is one of the most prevalent, costly, and burdensome diseases in the world, affecting 382 million people worldwide in 2013. What does the typical demographic patient profile look like? And how has treatment… Continue Reading

0

Real-World Evidence: Why Patients Matter.

“Take 2 tablets and call me in the morning“ We’ve moved, finally, beyond assuming that an off-the-cuff statement like “take 2 and call me in the morning” is sufficient.  But maybe we haven’t moved far enough to ask the important… Continue Reading

0

Is Your RWE Study In the Weeds? Meet Some Experts Who Can Help.

This year, you can’t swing the proverbial “dead cat” without running into a meeting on Real World Evidence.  This flurry of activity portends good things in that decision-makers are placing greater importance on real world effectiveness data.  Most of us… Continue Reading